JOHANNESBURG, June 24th , 2024 ' Inflammatory bowel disease (IBD) is characterised by chronic inflammation of the gastrointestinal (GI) tract (1), which will affect the comfort, and therefore quality of life, of patients with the condition.
Apart from the pain and ongoing inconvenience experienced by patients, these differences from ones peers could lead to a negative self-perception and fear of ....
- Hlengiwe Makhubele
- 24 Jun 2024
- 625
Organisation : Janssen Pharmaceutical Companies Of Johnson & Johnson
Tags: #JanssenPharmaceuticalCompaniesOfJohnson&Jphnson